Life Sciences IPOs Take a Breather December 02, 2013 | Press Release

Booming IPO Market Improving M&A Terms for Private Biotechs November 01, 2013 | Press Release

ADMA Biologics, Inc. Announces Pricing October 18, 2013 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.

Submit a Business Plan

Do great things with us.Click here 
Venture Capital

2011 News Archive


Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter

Biotech stocks fall with the market as financing activity slows

October 03, 2011

› Learn more


Promise of Personalized Medicine Remains Unrealized

Burrill & Company Meeting Explores the Challenges Faced by the Drugs, Tools, and Diagnostics Companies Leading a Revolution in Healthcare

September 15, 2011

› Learn more


Volatile Markets in August Take a Toll on Life Sciences IPOs

Burrill & Company says poor performance for new issues, depressed stocks, could fuel surge in M&A

August 31, 2011

› Learn more


New Drug Approvals in 2011 Already Match 2010 Total

Burrill & Company sees environment improving for life sciences, but macroeconomic threats persist.

July 31, 2011

› Learn more


M&A Has Failed to Build Value for Pharma, Burrill Annual Biotech Report Finds

Pressure to Find Better Models to Discover and Develop New Drugs Increases

April 12, 2011

› Learn more


Boom Times for Genomics Startups

Investment is picking up as sales of gene sequencing machines surge

March 17, 2011

› Learn more

News Archive: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2004 | 2003 | 2002 | View All